Insurance claim data from the USA showed that RA patients with a previous history of cardiovascular disease [72], comorbidity of type 2 diabetes mellitus [73], or age over 65 years [74] had a lower HR for cardiovascular events when using abatacept than when using TNF inhibitors. This evidence concerns the gene TNF and cardiovascular disorder.